Cargando…

Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia-inducible factor-1α expression is involved in prostate epithelial malignancy

Cancer stem cells (CSCs) have been identified in a variety of cancer types, including prostate cancer. The aim of the present study was to evaluate the immunohistochemical expression of NANOG, octamer 4 (OCT4), cluster of differentiation 133 (CD133) and NESTIN, which are all CSC markers, and assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	MIYAZAWA, KATSUHITO, TANAKA, TAKUJI, NAKAI, DAN, MORITA, NOBUYO, SUZUKI, KOJI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114613/ https://www.ncbi.nlm.nih.gov/pubmed/25120646 http://dx.doi.org/10.3892/ol.2014.2274

Ejemplares similares

Immunohistochemical Expression of Nanog and Its Relation with Clinicopathologic Characteristics in Breast Ductal Carcinoma
por: Saravi, Omid Emadian, et al.
Publicado: (2019)

Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma
por: Abdallah, Rania Abdallah, et al.
Publicado: (2019)

Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium
por: Al-Kaabi, Methaq, et al.
Publicado: (2022)

Ureterosciatic hernia treated with ureteral stent placement
por: Nakazawa, Yusuke, et al.
Publicado: (2018)

Forced Expression of Nanog or Esrrb Preserves the ESC Status in the Absence of Nucleostemin Expression
por: Katano, Miyuki, et al.
Publicado: (2015)

Pathobiology and Chemoprevention of Bladder Cancer
por: Tanaka, Takuji, et al.
Publicado: (2011)

Midkine and NANOG Have Similar Immunohistochemical Expression Patterns and Contribute Equally to an Adverse Prognosis of Oral Squamous Cell Carcinoma
por: Kim, Hyun-Min, et al.
Publicado: (2017)

Immunohistochemical Expression and Localization of Somatostatin Receptor Subtypes in Androgen Ablated Prostate Cancer
por: Mazzucchelli, Roberta, et al.
Publicado: (2010)

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study
por: Samir Sayed, Rasha Mohamed, et al.
Publicado: (2023)

Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells
por: Espinoza, Ingrid, et al.
Publicado: (2016)

Low-Level Nanog Expression in the Regulation of Quiescent Endothelium
por: Baruah, Jugajyoti, et al.
Publicado: (2020)

Immunohistochemical panel to characterize canine prostate carcinomas according to aberrant p63 expression
por: Fonseca-Alves, Carlos Eduardo, et al.
Publicado: (2018)

Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia
por: Filipovski, Vanja, et al.
Publicado: (2017)

Genome editing demonstrates that the −5 kb Nanog enhancer regulates Nanog expression by modulating RNAPII initiation and/or recruitment
por: Agrawal, Puja, et al.
Publicado: (2020)

Microvascular density and immunohistochemical expression of VEGF, VEGFR-1 and VEGFR-2 in benign prostatic hyperplasia, high-grade prostate intraepithelial neoplasia and prostate cancer
por: Grivas, Nikolaos, et al.
Publicado: (2016)

Maspin Expression in Epithelial Skin Tumours: An Immunohistochemical Study
por: Abdou, Asmaa Gaber, et al.
Publicado: (2011)

The role of Nanog expression in tamoxifen-resistant breast cancer cells
por: Arif, Khalid, et al.
Publicado: (2015)

Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma
por: Grubelnik, Gašper, et al.
Publicado: (2020)

Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer
por: Kolijn, Kimberley, et al.
Publicado: (2015)

Recurrence of renal cell carcinoma after simultaneous radical nephrectomy and cadaver renal transplant
por: Inoue, Shinya, et al.
Publicado: (2022)

Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells
por: Ye, Feng, et al.
Publicado: (2008)

A study to correlate histopathology, biochemical marker and immunohistochemical expression of sex-steroid receptors in prostatic growth
por: Naskar, Sukla, et al.
Publicado: (2014)

Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
por: Fankhauser, Christian D., et al.
Publicado: (2017)

Decreased expression of bone morphogenetic protein-2 is correlated with biochemical recurrence in prostate cancer: Immunohistochemical analysis
por: Tae, Bum Sik, et al.
Publicado: (2018)

Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions
por: Ahmed, Eiman Siddig, et al.
Publicado: (2020)

Prostate-Specific Membrane Antigen (PSMA) Expression in The Neovasculature of High Grade Gliomas (Histopathological and Immunohistochemical Study)
por: Abdel Maguid, Mona Salah-Eldin, et al.
Publicado: (2023)

Polypeptide Expression in Prostate Hyperplasia and Prostate Adenocarcinoma
por: Alaiya, Ayodele, et al.
Publicado: (2000)

Prognostic significance of NANOG expression in solid tumors: a meta-analysis
por: Zhao, Lingqiong, et al.
Publicado: (2018)

Ino80 promotes cervical cancer tumorigenesis by activating Nanog expression
por: Hu, Jing, et al.
Publicado: (2016)

NANOG initiates epiblast fate through the coordination of pluripotency genes expression
por: Allègre, Nicolas, et al.
Publicado: (2022)

High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma
por: Knipper, Karl, et al.
Publicado: (2023)

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
por: Jeter, Collene R., et al.
Publicado: (2011)

Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer
por: Verrill, Clare, et al.
Publicado: (2015)

5‐ARI induces autophagy of prostate epithelial cells through suppressing IGF‐1 expression in prostate fibroblasts
por: Yang, Bo‐Yu, et al.
Publicado: (2019)

PUMA and NOXA Expression in Tumor-Associated Benign Prostatic Epithelial Cells Are Predictive of Prostate Cancer Biochemical Recurrence
por: Clairefond, Sylvie, et al.
Publicado: (2020)

Inflammation induced by lipopolysaccharide advanced androgen receptor expression and epithelial-mesenchymal transition progress in prostatitis and prostate cancer
por: Wang, Guang-Chun, et al.
Publicado: (2021)

Correlation of AR, EGFR, and HER2 Expression Levels in Prostate Cancer: Immunohistochemical Analysis and Chromogenic In Situ Hybridization
por: Baek, Kwang Hyun, et al.
Publicado: (2012)

Expression of Autophagy Markers Beclin1 and LC3B in Prostatic Carcinoma: An Immunohistochemical Case-Control Study
por: Holah, Nanis S., et al.
Publicado: (2022)

Prostatic malacoplakia. An ultrastructural and immunohistochemical study.
por: Park, S. H., et al.
Publicado: (1987)

NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma
por: WATANABE, MASAHIRO, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ifua675sadkh9e03hlcp8kkfoj